BackBriaCell Therapeutics Overview
BriaCell Therapeutics Corp - Ordinary Shares - New

BriaCell Therapeutics Discounted Cash Flow

DCF Analysis for BCTX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$5.48

Current Fair Value

$5.48
100.0% Upside

Undervalued by 100.0% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading